Intracellular immunization against Aujeszky's disease

针对 Aujeszky 病的细胞内免疫

基本信息

  • 批准号:
    04660312
  • 负责人:
  • 金额:
    $ 1.34万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
  • 财政年份:
    1992
  • 资助国家:
    日本
  • 起止时间:
    1992 至 1993
  • 项目状态:
    已结题

项目摘要

"Intracellular immunization" using transdominant or dominant negative mutants, of viral proteins is considered to be a new approach to antiviral therapy in humans and to germ-line transformation in animals to conger resistance to virus infection. To obtain effective repressors of pseudorabies virus (PRV) immediate-early (IE) gene expression, a transdominant gene of PRV IE gene encoding an IE protein (IE180) and a chimeric gene encoding a fusion protein consisting of the DNA-binding domain of IE180 and tail-truncated Vmw65 lacking the transcription activation domain were constructed.PRV IE180 functions as a strong transactivator of several different promoters and also as a repressor of its own transcription. To map the functional domains of IE180, weprepared various truncated mutants and analyzed their transcriptional regulatory, activities using the chloramphenicol acetyl transferase assay. Analysis of nutants truncated from the carboxy-terminal end of the 1460-amino acid polypeptide s … More howed that a polypeptide possessing amino acids 1 to 1063 retained significant functions of transactivation and autoregulation potential. On the other hand, removing amino acids 1 to 132 resulted in a complete loss of transactivation potential, indicating that the domain responsible for transactivation is located in the amino-terminal end of the IE180. Additional amino-terminal truncation up to amino acid 427 did not affect the autoregulation activity, indicating that the region between amino acids 428 and 1063 has autoregulation potential. Finally, a CPK cell line stably transformed with the truncated gene showed resistance to PRV intection.A chimeric gene encoding a fusion protein consisting of the DNA-binding domain of the IE180 of PRV and a tail-truncated virion protein, Vmw65, lacking the transcription activation domain of herpes simplex virus 1 was constructed. The chimeric gene product inhibited transcription from the PRV IE promoter in a transient expression assay. The denovo synthesis of infectious virus was suppressed following cotransfection with the chimeric gene expression plasmid and PRV genomic DNA.A HeLa cell line stably transformed with the chimeric gene showed remarkable resistance to PRV infection. In the transformed cells infected with PRV, the PRV IE gene transcription was repressed, indicating that the resistance to PRV infection was due interference with the IE gene transcription by the fusion protein.These results indicate that the transdominant gene and the chimeric gene act as a powerful trans-gene for "intracellular immunization" against pseudorabies. Less
利用病毒蛋白的跨显性或显性阴性突变体的“细胞内免疫”被认为是人类抗病毒治疗和动物种系转化以延长病毒感染抵抗力的新方法。为了获得有效抑制伪狂犬病毒(PRV)即刻早期(IE)基因表达的基因,构建了编码IE蛋白的伪狂犬病毒IE基因的跨显性基因(IE180)和编码由IE180的dna结合域和缺失转录激活域的尾部截断的Vmw65组成的融合蛋白的嵌合基因(chimeric gene)。PRV IE180是几种不同启动子的强反激活子,也是其自身转录的抑制子。为了绘制IE180的功能域,我们制备了各种截断突变体,并使用氯霉素乙酰转移酶测定分析了它们的转录调控活性。对含有1460个氨基酸的多肽羧基末端截短的nutants的分析表明,含有1 ~ 1063个氨基酸的多肽保留了显著的转激活和自调节电位功能。另一方面,去除氨基酸1 ~ 132导致完全丧失了转激活的潜力,这表明负责转激活的结构域位于IE180的氨基末端。对氨基酸427的氨基末端额外截断不影响自调节活性,表明428和1063之间的氨基酸区域具有自调节潜力。最后,用截断的基因稳定转化的CPK细胞系显示出对PRV感染的抗性。构建了由PRV IE180的dna结合域与缺乏单纯疱疹病毒1转录激活域的尾截断病毒粒子蛋白Vmw65组成的融合蛋白的嵌合基因。嵌合基因产物在瞬时表达实验中抑制了PRV IE启动子的转录。嵌合基因表达质粒与PRV基因组DNA共转染后,传染性病毒的脱氧合成受到抑制。嵌合基因稳定转化的HeLa细胞系对PRV感染表现出显著的抗性。在感染PRV的转化细胞中,PRV IE基因转录受到抑制,表明该融合蛋白干扰了IE基因转录,从而对PRV感染产生了抗性。这些结果表明,跨显性基因和嵌合基因作为一种强大的抗伪狂犬病“细胞内免疫”的转基因基因。少

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ONO Etsuro其他文献

ONO Etsuro的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ONO Etsuro', 18)}}的其他基金

Generation of transboundary animal diseases-resistant animals by genetic modification technologies to Rab-GTPases genes
利用Rab-GTP酶基因转基因技术培育跨境动物抗病动物
  • 批准号:
    20K20577
  • 财政年份:
    2020
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Pioneering)
Generation of transgenic mice expressing soluble forms of Siglecs as a model for influenza-resistant pigs
表达可溶形式 Siglecs 的转基因小鼠的产生作为抗流感猪的模型
  • 批准号:
    22380161
  • 财政年份:
    2010
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
GENERATION OF TRANSGENIC MICE EXPRESSING SOLUBLE FORM OF PORCINE NECTIN-1 AS A MODEL FOR PSEUDORABIES-RESISTANT LIVE STOCK
表达可溶形式的猪 NECTIN-1 的转基因小鼠的产生作为抗伪狂犬病家畜的模型
  • 批准号:
    17580265
  • 财政年份:
    2005
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Generation of Pseudorabies-resistant Animals by Germ-line Transformation
通过种系转化产生抗伪狂犬病动物
  • 批准号:
    12556048
  • 财政年份:
    2000
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Neuropathogenic abnormalities in transgenic mice expressing transcription factors of neurotropic viruses in the central nervous system
中枢神经系统中表达嗜神经病毒转录因子的转基因小鼠的神经病理性异常
  • 批准号:
    11660291
  • 财政年份:
    1999
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Bovine herpesvirus 4 as a vaccine platform for African swine fever virus antigens in pigs
牛疱疹病毒 4 作为猪非洲猪瘟病毒抗原的疫苗平台
  • 批准号:
    BB/Y006224/1
  • 财政年份:
    2024
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Research Grant
Under Pressure: Biophysical Mapping of Herpesvirus Capsid Assembly and Genome Packaging
压力之下:疱疹病毒衣壳组装和基因组包装的生物物理图谱
  • 批准号:
    10685823
  • 财政年份:
    2023
  • 资助金额:
    $ 1.34万
  • 项目类别:
Noncoding RNAs in gamma-Herpesvirus Biology and AIDS Malignancies
γ-疱疹病毒生物学和艾滋病恶性肿瘤中的非编码 RNA
  • 批准号:
    10812041
  • 财政年份:
    2023
  • 资助金额:
    $ 1.34万
  • 项目类别:
Use of a non-human primate model to define the role of T cell immune responses in persistent Kaposi sarcoma-associated herpesvirus infection and Kaposi sarcoma pathogenesis
使用非人灵长类动物模型来定义 T 细胞免疫反应在持续性卡波西肉瘤相关疱疹病毒感染和卡波西肉瘤发病机制中的作用
  • 批准号:
    10667986
  • 财政年份:
    2023
  • 资助金额:
    $ 1.34万
  • 项目类别:
Exploring herpesvirus exonucleases as potential antiviral targets
探索疱疹病毒核酸外切酶作为潜在的抗病毒靶点
  • 批准号:
    10825475
  • 财政年份:
    2023
  • 资助金额:
    $ 1.34万
  • 项目类别:
Development of cocktail vaccines against poultry red mites using the recombinant turkey herpesvirus
使用重组火鸡疱疹病毒开发针对家禽红螨的鸡尾酒疫苗
  • 批准号:
    23H02370
  • 财政年份:
    2023
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
International Herpesvirus Workshop
国际疱疹病毒研讨会
  • 批准号:
    10752979
  • 财政年份:
    2023
  • 资助金额:
    $ 1.34万
  • 项目类别:
Project 3 - Characterizing the Amplification Factories of Epstein-Barr Virus and Kaposi's Sarcoma-associated Herpesvirus
项目 3 - 描述 Epstein-Barr 病毒和卡波西肉瘤相关疱疹病毒的扩增工厂
  • 批准号:
    10910337
  • 财政年份:
    2023
  • 资助金额:
    $ 1.34万
  • 项目类别:
Human herpesvirus 6 and chromosomal integration
人类疱疹病毒6型和染色体整合
  • 批准号:
    468828
  • 财政年份:
    2022
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Operating Grants
HSV/VZV chimeric viruses for identifying critical virus herpesvirus assembly interactions
HSV/VZV 嵌合病毒用于识别关键病毒疱疹病毒组装相互作用
  • 批准号:
    10442813
  • 财政年份:
    2022
  • 资助金额:
    $ 1.34万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了